New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 18, 2014
07:56 EDTLCILannett signs agreement with Symplmed
Lannett announced that it has signed an agreement with Symplmed to be the exclusive distributor in the U.S. of an authorized generic version of ACEON in 2 mg, 4 mg and 8 mg dosage strengths. According to IMS, annual total sales of Perindopril Erbumine Tablets, 2 mg, 4 mg and 8 mg, at Average Wholesale Price were approximately $3.5M. The company expects to commence shipping the product shortly.
News For LCI From The Last 14 Days
Check below for free stories on LCI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 22, 2014
07:29 EDTLCILannett launches Oxycodone Hydrochloride Oral Solution
Lannett Company announced that it has commenced shipping its recently approved Oxycodone Hydrochloride Oral Solution USP, 100 mg per 5 mL. According to IMS, annualized sales of Oxycodone Hydrochloride Oral Solution USP, 100 mg per 5 mL, at Average Wholesale Price were approximately $43M. “We previously expected to begin marketing our Oxycodone Hydrochloride Oral Solution product in the second half of our fiscal year,” said Arthur P. Bedrosian, president and CEO of Lannett. “The earlier than anticipated launch combined with continued strong sales of our Digoxin product in the first quarter provide us with additional confidence to reaffirm our financial guidance for the fiscal 2015 full year.”
September 17, 2014
11:01 EDTLCIActavis drops after NY AG seeks to block Alzheimer drug switch
Subscribe for More Information
September 16, 2014
07:55 EDTLCILannett voluntarily conducts internal review in response to CT AG inquiry
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use